TUSTIN, March 1, 2010: Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that senior management will present at the following upcoming investor conferences:
Peregrine will present at the Cowen and Company 30th Annual Health Care Conference on Monday, March 8, 2010 at 3:15pm EST. The conference will be held at The Boston Marriott Copley Place. For more information about this conference, please visit: http://www.cowen.com/UpcomingConferences.html
Peregrine will also present at the ROTH 22nd Annual OC Growth Stock Conference on Wednesday, March 17, 2010 at 12:30pm PDT. The conference will be held at the Ritz-Carlton, Laguna Niguel. For more information about this conference, please visit: http://www.roth.com/main/Page.aspx?PageID=7226
A live webcast of the company's presentation at the ROTH 22nd Annual OC Growth Stock Conference will be available at the Investors section of Peregrine's website at http://www.peregrineinc.com .
ABOUT PEREGRINE PHARMACEUTICALS Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and serious virus infections. The company is pursuing 3 separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. ( http://www.avidbio.com ), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com . Contacts: GendeLLindheim BioCom Partners Investors: 800-987-8256, info@peregrineinc.com Media: Barbara Lindheim, 212-918-4650
= = = = = = = = = = Mar8-11 2010: “Cowen’s 30th Annual Health Care Conf.”, Boston http://www.cowen.com/Conferences.html http://www.cowen.com/UpcomingConferences.html 3-8-10 3:15pm: Peregrine Pharmaceuticals …A few other biotechs/pharmas that are presenting: • Abbott Labs • Eli Lilly • Savient Pharmaceuticals • Questcor Pharmaceuticals • Myriad Genetics • Incyte Corp. • ImmunoGen • Salix Pharmaceuticals • Vical Inc. • Myriad Genetics • Vertex • XOMA Ltd. • Novavax, Inc.
Mar15-17 2010: “22nd Annual OC Growth Stock Conf. (ROTH Cap.Partners’)”, DanaPT, CA http://www.roth.com/main/Page.aspx?PageID=7226 Please join ROTH for its annual 3-day conference that brings together executives from over 350 growth companies including 100 U.S.-listed Chinese companies. This event is designed to provide investors with a unique opportunity to gain insight into small & mid-cap growth companies across a variety of sectors, including energy, software, technology, industrials, healthcare, media, consumer, and retail. We combine company presentations, Q&A sessions, and mgt. 1-on-1 meetings to provide our institutional clients with extensive interaction with senior mgt. to gain in-depth insights into each company. Presenting on 3-17-10 12:30pm (Track: Healthcare): Peregrine Pharmaceuticals Inc. (PPHM): Biotechnology & Healthcare …A few other biotechs that are presenting: • SciClone Pharmaceuticals, Inc. (SCLN): China Track • Achillion Pharmaceuticals (ACHN) • Anadys Pharmaceuticals (ANDS) • Cell Therapeutics, Inc. (CTIC) • Celldex Therapeutics Inc (CLDX) • Dendreon Corp. (DNDN) • GenVec Inc. (GNVC) • Halozyme Therapeutics, Inc. (HALO) • Inhibitex (INHX) • Novavax, Inc. (NVAX) • Oxigene Inc. (OXGN) • SuperGen Inc. (SUPG) • Vertex Pharmaceuticals (VRTX): China Track • Vical Incorporated (VICL) 2-23-10 ROTH PR: http://wireless.sys-con.com/node/1295047
Market Data 
Markets 
AI
